---
figid: PMC2939308__nihms226018f1
figlink: /pmc/articles/PMC2939308/figure/F1/
number: F1
caption: LOV inhibits HMG-CoA reductase of the mevalonate-pathway resulting in the
  depletion of cholesterol and isoprenoids i.e., farnesyl-pp and geranylgeranyl-pp
  responsible for an inhibition of Ras and RhoA signaling, respectively. RhoA mediated
  inhibition of ROCK signaling induces p38MAPK activation, which in turn induces COX-2
  mediated production of PPAR-γ activators i.e., 15d-PGJ2 via increased release of
  arachidonic acid (AA) from phospholipids (PP) metabolism by cPLA2. Subsequently,
  activated PPAR-γ induces PTEN which in turn inhibits PI3K-Akt signaling thus inhibits
  OPC proliferation via induction of the expression of cell cycle inhibitory proteins
  i.e., p21Cip1 and p27Kip1. These events subsequently induce the expression of myelin
  proteins leading to the differentiation of OPCs. Box depicts the mevalonate pathway,
  NT as neurotrophic factor, PKC as protein kinase C, SOX10 and sp1 as transcription
  factors. Pharmacological and biological agents used in the study are bolded (please
  see text for details).
pmcid: PMC2939308
papertitle: Activation of PPAR-γ and PTEN Cascade Participates in Lovastatin-mediated
  Accelerated Differentiation of Oligodendrocyte Progenitor Cells.
reftext: Ajaib S Paintlia, et al. Glia. ;58(14):1669-1685.
pmc_ranked_result_index: '42424'
pathway_score: 0.9599373
filename: nihms226018f1.jpg
figtitle: Activation of PPARG and PTEN Cascade Participates in Lovastatin-mediated
  Accelerated Differentiation of Oligodendrocyte Progenitor Cells
year: ''
organisms: Homo sapiens
ndex: ffb63b02-dede-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2939308__nihms226018f1.html
  '@type': Dataset
  description: LOV inhibits HMG-CoA reductase of the mevalonate-pathway resulting
    in the depletion of cholesterol and isoprenoids i.e., farnesyl-pp and geranylgeranyl-pp
    responsible for an inhibition of Ras and RhoA signaling, respectively. RhoA mediated
    inhibition of ROCK signaling induces p38MAPK activation, which in turn induces
    COX-2 mediated production of PPAR-γ activators i.e., 15d-PGJ2 via increased release
    of arachidonic acid (AA) from phospholipids (PP) metabolism by cPLA2. Subsequently,
    activated PPAR-γ induces PTEN which in turn inhibits PI3K-Akt signaling thus inhibits
    OPC proliferation via induction of the expression of cell cycle inhibitory proteins
    i.e., p21Cip1 and p27Kip1. These events subsequently induce the expression of
    myelin proteins leading to the differentiation of OPCs. Box depicts the mevalonate
    pathway, NT as neurotrophic factor, PKC as protein kinase C, SOX10 and sp1 as
    transcription factors. Pharmacological and biological agents used in the study
    are bolded (please see text for details).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK13
  - MAPK14
  - MAPK12
  - MBP
  - PIK3R6
  - PIK3CG
  - PIK3CA
  - PIK3CB
  - MAPK10
  - PRKCI
  - MAPK11
  - PIK3R3
  - AKT1
  - PRKD3
  - NTS
  - CDKN1B
  - PIK3R5
  - PIK3R4
  - PRKCE
  - PRKCG
  - PIK3CD
  - MAPK9
  - AKT2
  - PRKCA
  - PRKCQ
  - PRKCZ
  - PRKCD
  - KAT5
  - AKT3
  - PRKCB
  - PTEN
  - MAPK1
  - PRKCH
  - C3
  - CDK4
  - KRAS
  - NRAS
  - MAPK3
  - MAPK8
  - HRAS
  - SP1
  - SOX10
  - Ciglitazone
  - Cholesterol
  - Mevalonate
  - Cancer
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: (MBP)
  symbol: MBP
  source: hgnc_symbol
  hgnc_symbol: MBP
  entrez: '4155'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: NTs
  symbol: NTS
  source: hgnc_symbol
  hgnc_symbol: NTS
  entrez: '4922'
- word: 221P'&p27Kip1
  symbol: P27KIP1
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN1B
  entrez: '1027'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: CPLA2
  symbol: cPLA2
  source: hgnc_alias_symbol
  hgnc_symbol: KAT5
  entrez: '10524'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: C3
  symbol: C3
  source: hgnc_symbol
  hgnc_symbol: C3
  entrez: '718'
- word: CDK4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: SOX10/Sp1
  symbol: SP1
  source: hgnc_symbol
  hgnc_symbol: SP1
  entrez: '6667'
- word: SOX10/Sp1
  symbol: SOX10
  source: hgnc_symbol
  hgnc_symbol: SOX10
  entrez: '6663'
chemicals:
- word: Ciglitazone
  source: MESH
  identifier: C039671
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: Mevalonate
  source: MESH
  identifier: D008798
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2939308__F1
redirect_from: /figures/PMC2939308__F1
figtype: Figure
---
